Reactive oxygen species are important mediators of cellular injury via destruction of membranes or alteration of enzyme activities. The polyunsaturated fatty acids of the membranes are particularly susceptible to free radical attack, ultimately forming lipid hydroperoxides. Iron catalyzes lipid peroxidation because of its ability to react with oxygen to form species capable of initiating peroxidative events. Both Fe(I1) and Fe(II1) are required for the catalysis of lipid peroxidation [ 11.
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Estrogens and catecholestrogens have been shown to inhibit microsomal lipid peroxidation stimulated by iron and NADPH [2, 3] , which involves the enzymatic reduction of Fe(II1) by NADPH-cytochrome P450 reductase. Both the reductase system and the cytochrome P450 itself participate also in the metabolic transformations (hydroxylations) of estrogens into catecholestrogens [4] .
The present work was aimed to investigate if the antioxidant action of estrogens is caused by the inhibition of the reduction of the Fe(III)/ADP complex and/or by interactions of estrogens with the cytochrome P450 activity.
We have used rat liver microsomes, prepared as described previously [5] , as the lipid source. The microsomes (0.3 mg/ml) were resuspended in Tris/HCl buffer, pH 7.4, and preincubated with the agents dissolved in DMSO (1 %) at 37"C, under air. Reactions were initiated by the addition of Fe3CVADP (25 pM/2.5 mM) and NADPH (200pM). Reduction of Fe(II1) was monitored by estimating the formation rate of the Fe(II)/I , 10-phenantroline complex. NADPHcytochrome P450 reductase activity was estimated according to Lake [6] by following the reduction of cytochrome c at 550 nm for 2 min. The activity of 7-ethoxycoumarin 0-deethylase was measured fluorimetrically [7] .
As can be seen in Figure 1 , both El and E2 inhibited the Fe(II1) reduction in a dose-dependent manner, probably by diverting reduction equivalents from the peroxidation process to its own metabolization. DES similarly affected the Fe(II1) reduction. By contrast, 2-OHE2, the most potent antioxidant [8] , increased markedly the formation of Fe(I1) (Fig. I) , suggesting a different inhibitory mechanism.
Abbreviations used: El, estrone; E2, 17I3-estradiol; DES, diethylstilbestrol; 2-OHE2, 2-hydroxyestradiol. We also studied the effects of these agents on the NADPH-cytochrome P450 reductase activity. 2-Hydroxyestradiol itself reduced cytochrome c and could not be assayed for the reductase activity. The rest of the molecules (El, E2, and DES) had no effects on transfer of electrons from NADPH to oxidized cytochrome c (control = 0.15 lfO.O1 AAsso/min/mg protein). However, the estrogenic compounds inhibited the NADPH-supported monooxygenase activity represented by 7-ethoxycoumarin 0-deethylase. At the concentration of 25 pM, El, E2, DES and 2-OHE2 inhibited the enzyme activity a 18, 36, 49, and 32% (specific activity in controls, 0.66f0.08 nmol/min/mg protein). These findings indicate interactions between the estrogens and cytochrome P450. This work was supported by Grants UPV/O8 1.327-EA101/92 and UPV/O81.327-EA044/93.
